Pekin, Singer Strauss Asset Management »

Inhibrx Biosciences shares owned by Pekin, Singer Strauss Asset Management

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Pekin, Singer Strauss Asset Management from 13F filings

Historical chart of Pekin, Singer Strauss Asset Management investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Pekin, Singer Strauss Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Pekin, Singer Strauss Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $273k 18k 15.40
2024-09-30 $400k 26k 15.66

More positions owned by Pekin, Singer Strauss Asset Management

Sprott Physical Gold Tr Unit (PHYS)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Cameco Corporation (CCJ)
Apple (AAPL)
Exxon Mobil Corporation (XOM)
WESCO International (WCC)
Sprott Physical Gold & Silve Tr Unit (CEF)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
CF Industries Holdings (CF)
Energy Transfer Com Ut Ltd Ptn (ET)
Agnc Invt Corp Com reit (AGNC)
Vaneck Merk Gold Etf Gold Shs (OUNZ)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)

View all positions for Pekin, Singer Strauss Asset Management

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
BlackRock
HighTower Advisors
Vanguard Group
Walleye Trading Advisors
Sofinnova Ventures
Slotnik Capital
Millennium Management
Geode Capital Management
Caption Management
Castalian Partners
State Street Corporation
Kennedy Capital Management
Arrowpoint Asset Management

View all funds holding Inhibrx Biosciences